|
Name |
Zinniol
|
Molecular Formula | C15H22O4 | |
IUPAC Name* |
[2-(hydroxymethyl)-3-methoxy-4-methyl-5-(3-methylbut-2-enoxy)phenyl]methanol
|
|
SMILES |
CC1=C(C=C(C(=C1OC)CO)CO)OCC=C(C)C
|
|
InChI |
InChI=1S/C15H22O4/c1-10(2)5-6-19-14-7-12(8-16)13(9-17)15(18-4)11(14)3/h5,7,16-17H,6,8-9H2,1-4H3
|
|
InChIKey |
DUMQPTRUYCCSEZ-UHFFFAOYSA-N
|
|
Synonyms |
Zinniol; 17811-28-8; [2-(hydroxymethyl)-3-methoxy-4-methyl-5-(3-methylbut-2-enoxy)phenyl]methanol; 3-Methoxy-4-methyl-5-(3-methyl-2-butenyloxy)-1,2-benzenedimethanol; ACon1_002206; CHEBI:10117; 2XM821R13R; NSC-125427; AC1L3DE3; UNII-2XM821R13R; AC1Q563R; NSC 125427; SCHEMBL3117461; CHEMBL1973111; DTXSID10170425; ZINC900428; Zinniol, >=90% (LC/MS-UV); NSC125427; BS-1543; NCGC00179724-01; NCI60_000594; BRD-K31553865-001-01-8; Q27108590; 1,2-Benzenedimethanol, 3-methoxy-4-methyl-5-((3-methyl-2-butenyl)oxy)-; NCGC00179724-02![2-(hydroxymethyl)-3-methoxy-4-methyl-5-(3-methylbut-2-enoxy)phenyl]methanol
|
|
CAS | 17811-28-8 | |
PubChem CID | 87317 | |
ChEMBL ID | CHEMBL1973111 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 266.33 | ALogp: | 2.0 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 58.9 | Aromatic Rings: | 1 |
Heavy Atoms: | 19 | QED Weighted: | 0.777 |
Caco-2 Permeability: | -4.55 | MDCK Permeability: | 0.00000815 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.106 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.802 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.915 | Plasma Protein Binding (PPB): | 82.69% |
Volume Distribution (VD): | 2.273 | Fu: | 12.03% |
CYP1A2-inhibitor: | 0.842 | CYP1A2-substrate: | 0.702 |
CYP2C19-inhibitor: | 0.036 | CYP2C19-substrate: | 0.798 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.373 |
CYP2D6-inhibitor: | 0.21 | CYP2D6-substrate: | 0.813 |
CYP3A4-inhibitor: | 0.026 | CYP3A4-substrate: | 0.437 |
Clearance (CL): | 9.849 | Half-life (T1/2): | 0.896 |
hERG Blockers: | 0.031 | Human Hepatotoxicity (H-HT): | 0.866 |
Drug-inuced Liver Injury (DILI): | 0.048 | AMES Toxicity: | 0.189 |
Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.349 | Carcinogencity: | 0.193 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.092 |
Respiratory Toxicity: | 0.021 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004833 | 0.737 | D07MUN | 0.292 | ||||
ENC005607 | 0.606 | D0L5FY | 0.282 | ||||
ENC004636 | 0.413 | D06BLQ | 0.254 | ||||
ENC004817 | 0.400 | D0YH0N | 0.244 | ||||
ENC004638 | 0.385 | D05QDC | 0.237 | ||||
ENC005000 | 0.377 | D0B1IP | 0.235 | ||||
ENC004637 | 0.358 | D04FBR | 0.232 | ||||
ENC005943 | 0.355 | D05VIX | 0.222 | ||||
ENC004639 | 0.347 | D0A8FB | 0.217 | ||||
ENC004503 | 0.346 | D0Y7TS | 0.212 |